{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Activitat 1: Python i Data Science\n",
    "\n",
    "# **Exploració de la base de dades DrugCentral**\n",
    "\n",
    "## Bioinformàtica - UF3 \n",
    "\n",
    "    \n",
    "+ **Nom estudiant:**\n",
    "+ **Data d'entrega:** Diumenge 18 de Desembre 2022\n",
    "\n",
    "*NOTA1: Per cada dia d'entrega més tard es descomptarà un 10% de la nota de la pràctica.*\n",
    "\n",
    "*NOTA2: L'script s'ha d'executar sense errors i produir els resultats, fitxers i figures que es demanen. És aconsellable abans d'entregar reiniciar el kernel del notebook (Kernel > Restart Kernel) i comprovar que totes les cel·les del notebook s'executen sense errors una rere l'altre.* \n",
    "***"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**[DrugCentral](https://drugcentral.org/)**  és  una  base  de  dades  que  conté  informació  sobre  fàrmacs  elaborada  i mantinguda per la Divisió d’Informàtica Translacional de la Universitat de Nou Mèxic. Entre les seves dades, ens podem descarregar el fitxer `drug_target_interaction.tsv` (el teniu al MOODLE a l’apartat de l’Activitat 1). Aquesta taula conté dades d’interacció entre els fàrmacs i el seu lloc d'unió molecular, que són les proteïnes, a més d'altres camps com a quin organisme s'ha testejat, codis d'accès, etc. \n",
    "\n",
    "Els fàrmacs són **molècules petites** que **interaccionen** amb unes macromolècules pròpies del cos anomenades **proteïnes** i en modifiquen la seva funció aconseguint així un efecte terapèutic. Les proteïnes són molt diverses i participen en moltes funcions, entre les quals destaquen l'acceleració de reaccions (enzims) i reconeixement de substàncies (anticossos i receptors). \n",
    "\n",
    "L’objectiu d’aquesta activitat és utilitzar les llibreries de python que hem après per a explorar el contingut d’aquesta base de dades i extreure’n informació. Recordeu  que  jupyter-lab  permet crear cel·les  en  markdown  on  podeu explicar què esteu fent i quins resultats que heu obtingut. A algunes solucions es poden arribar aplicant diferents estratègies. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Importació dels mòduls\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Neteja i preparació de la base de dades\n",
    "\n",
    "**a) Importar el _dataframe_ amb el qual es treballarà les dades de DrugCentral**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DRUG_NAME</th>\n",
       "      <th>STRUCT_ID</th>\n",
       "      <th>TARGET_NAME</th>\n",
       "      <th>TARGET_CLASS</th>\n",
       "      <th>ACCESSION</th>\n",
       "      <th>GENE</th>\n",
       "      <th>SWISSPROT</th>\n",
       "      <th>ACT_VALUE</th>\n",
       "      <th>ACT_UNIT</th>\n",
       "      <th>ACT_TYPE</th>\n",
       "      <th>ACT_COMMENT</th>\n",
       "      <th>ACT_SOURCE</th>\n",
       "      <th>RELATION</th>\n",
       "      <th>MOA</th>\n",
       "      <th>MOA_SOURCE</th>\n",
       "      <th>ACT_SOURCE_URL</th>\n",
       "      <th>MOA_SOURCE_URL</th>\n",
       "      <th>ACTION_TYPE</th>\n",
       "      <th>TDL</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Sodium channel protein type 4 subunit alpha</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P35499</td>\n",
       "      <td>SCN4A</td>\n",
       "      <td>SCN4A_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Cytochrome P450 2D6</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P10635</td>\n",
       "      <td>CYP2D6</td>\n",
       "      <td>CP2D6_HUMAN</td>\n",
       "      <td>6.706859</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...</td>\n",
       "      <td>DRUG MATRIX</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily H me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q12809</td>\n",
       "      <td>KCNH2</td>\n",
       "      <td>KCNH2_HUMAN</td>\n",
       "      <td>4.890000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of wild-type human ERG channel expr...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily D me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q9UK17</td>\n",
       "      <td>KCND3</td>\n",
       "      <td>KCND3_HUMAN</td>\n",
       "      <td>4.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Prostaglandin E2 receptor EP1 subtype</td>\n",
       "      <td>GPCR</td>\n",
       "      <td>P34995</td>\n",
       "      <td>PTGER1</td>\n",
       "      <td>PE2R1_HUMAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17385</th>\n",
       "      <td>tucatinib</td>\n",
       "      <td>5389</td>\n",
       "      <td>Receptor tyrosine-protein kinase erbB-4</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>Q15303</td>\n",
       "      <td>ERBB4</td>\n",
       "      <td>ERBB4_HUMAN</td>\n",
       "      <td>6.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32241871</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17386</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 1</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P11362</td>\n",
       "      <td>FGFR1</td>\n",
       "      <td>FGFR1_HUMAN</td>\n",
       "      <td>9.400000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17387</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 2</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P21802</td>\n",
       "      <td>FGFR2</td>\n",
       "      <td>FGFR2_HUMAN</td>\n",
       "      <td>9.300000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17388</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 3</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P22607</td>\n",
       "      <td>FGFR3</td>\n",
       "      <td>FGFR3_HUMAN</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17389</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 4</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P22455</td>\n",
       "      <td>FGFR4</td>\n",
       "      <td>FGFR4_HUMAN</td>\n",
       "      <td>7.520000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>17390 rows × 20 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             DRUG_NAME  STRUCT_ID  \\\n",
       "0      levobupivacaine          4   \n",
       "1      levobupivacaine          4   \n",
       "2      levobupivacaine          4   \n",
       "3      levobupivacaine          4   \n",
       "4      levobupivacaine          4   \n",
       "...                ...        ...   \n",
       "17385        tucatinib       5389   \n",
       "17386      pemigatinib       5390   \n",
       "17387      pemigatinib       5390   \n",
       "17388      pemigatinib       5390   \n",
       "17389      pemigatinib       5390   \n",
       "\n",
       "                                             TARGET_NAME TARGET_CLASS  \\\n",
       "0            Sodium channel protein type 4 subunit alpha  Ion channel   \n",
       "1                                    Cytochrome P450 2D6       Enzyme   \n",
       "2      Potassium voltage-gated channel subfamily H me...  Ion channel   \n",
       "3      Potassium voltage-gated channel subfamily D me...  Ion channel   \n",
       "4                  Prostaglandin E2 receptor EP1 subtype         GPCR   \n",
       "...                                                  ...          ...   \n",
       "17385            Receptor tyrosine-protein kinase erbB-4       Kinase   \n",
       "17386                Fibroblast growth factor receptor 1       Kinase   \n",
       "17387                Fibroblast growth factor receptor 2       Kinase   \n",
       "17388                Fibroblast growth factor receptor 3       Kinase   \n",
       "17389                Fibroblast growth factor receptor 4       Kinase   \n",
       "\n",
       "      ACCESSION    GENE    SWISSPROT  ACT_VALUE  ACT_UNIT ACT_TYPE  \\\n",
       "0        P35499   SCN4A  SCN4A_HUMAN        NaN       NaN      NaN   \n",
       "1        P10635  CYP2D6  CP2D6_HUMAN   6.706859       NaN     IC50   \n",
       "2        Q12809   KCNH2  KCNH2_HUMAN   4.890000       NaN     IC50   \n",
       "3        Q9UK17   KCND3  KCND3_HUMAN   4.500000       NaN     IC50   \n",
       "4        P34995  PTGER1  PE2R1_HUMAN        NaN       NaN      NaN   \n",
       "...         ...     ...          ...        ...       ...      ...   \n",
       "17385    Q15303   ERBB4  ERBB4_HUMAN   6.500000       NaN     IC50   \n",
       "17386    P11362   FGFR1  FGFR1_HUMAN   9.400000       NaN     IC50   \n",
       "17387    P21802   FGFR2  FGFR2_HUMAN   9.300000       NaN     IC50   \n",
       "17388    P22607   FGFR3  FGFR3_HUMAN   9.000000       NaN     IC50   \n",
       "17389    P22455   FGFR4  FGFR4_HUMAN   7.520000       NaN     IC50   \n",
       "\n",
       "                                             ACT_COMMENT  \\\n",
       "0                                                    NaN   \n",
       "1      DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...   \n",
       "2      Inhibition of wild-type human ERG channel expr...   \n",
       "3                                                    NaN   \n",
       "4                                                    NaN   \n",
       "...                                                  ...   \n",
       "17385                                                NaN   \n",
       "17386                                                NaN   \n",
       "17387                                                NaN   \n",
       "17388                                                NaN   \n",
       "17389                                                NaN   \n",
       "\n",
       "                  ACT_SOURCE RELATION  MOA  MOA_SOURCE  \\\n",
       "0                  WOMBAT-PK      NaN  1.0      CHEMBL   \n",
       "1                DRUG MATRIX        =  NaN         NaN   \n",
       "2                     CHEMBL        =  NaN         NaN   \n",
       "3                  WOMBAT-PK        =  NaN         NaN   \n",
       "4                  WOMBAT-PK      NaN  NaN         NaN   \n",
       "...                      ...      ...  ...         ...   \n",
       "17385  SCIENTIFIC LITERATURE        =  NaN         NaN   \n",
       "17386  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17387  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17388  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17389  SCIENTIFIC LITERATURE        =  NaN         NaN   \n",
       "\n",
       "                                          ACT_SOURCE_URL  \\\n",
       "0                                                    NaN   \n",
       "1                                                    NaN   \n",
       "2      https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "3                                                    NaN   \n",
       "4                                                    NaN   \n",
       "...                                                  ...   \n",
       "17385        http://www.ncbi.nlm.nih.gov/pubmed/32241871   \n",
       "17386        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17387        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17388        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17389        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "\n",
       "                                          MOA_SOURCE_URL ACTION_TYPE    TDL  \\\n",
       "0      https://www.ebi.ac.uk/chembl/compound/inspect/...     BLOCKER  Tclin   \n",
       "1                                                    NaN         NaN  Tclin   \n",
       "2                                                    NaN         NaN  Tclin   \n",
       "3                                                    NaN         NaN  Tclin   \n",
       "4                                                    NaN         NaN  Tclin   \n",
       "...                                                  ...         ...    ...   \n",
       "17385                                                NaN   INHIBITOR  Tclin   \n",
       "17386  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17387  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17388  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17389                                                NaN   INHIBITOR  Tclin   \n",
       "\n",
       "           ORGANISM  \n",
       "0      Homo sapiens  \n",
       "1      Homo sapiens  \n",
       "2      Homo sapiens  \n",
       "3      Homo sapiens  \n",
       "4      Homo sapiens  \n",
       "...             ...  \n",
       "17385  Homo sapiens  \n",
       "17386  Homo sapiens  \n",
       "17387  Homo sapiens  \n",
       "17388  Homo sapiens  \n",
       "17389  Homo sapiens  \n",
       "\n",
       "[17390 rows x 20 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"drug_target_interaction.tsv\", sep=\"\\t\")\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**b) Mostra la següent informació:** [0.5 punts]\n",
    "- Nombre de files i columnes.\n",
    "- Nom de les variables.\n",
    "- Nombre de _missing values (NA)_ a cada una de les columnes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de files i columnes.\n",
      "files: 17390\n",
      "columnes: 20\n",
      "\n",
      "\n",
      "\n",
      "Nom de les variables:\n",
      "Index(['DRUG_NAME', 'STRUCT_ID', 'TARGET_NAME', 'TARGET_CLASS', 'ACCESSION',\n",
      "       'GENE', 'SWISSPROT', 'ACT_VALUE', 'ACT_UNIT', 'ACT_TYPE', 'ACT_COMMENT',\n",
      "       'ACT_SOURCE', 'RELATION', 'MOA', 'MOA_SOURCE', 'ACT_SOURCE_URL',\n",
      "       'MOA_SOURCE_URL', 'ACTION_TYPE', 'TDL', 'ORGANISM'],\n",
      "      dtype='object')\n",
      "\n",
      "\n",
      "\n",
      "Numero de NA:\n",
      " DRUG_NAME             0\n",
      "STRUCT_ID             0\n",
      "TARGET_NAME           0\n",
      "TARGET_CLASS          0\n",
      "ACCESSION           139\n",
      "GENE                464\n",
      "SWISSPROT           139\n",
      "ACT_VALUE          1722\n",
      "ACT_UNIT          17390\n",
      "ACT_TYPE           1721\n",
      "ACT_COMMENT        5738\n",
      "ACT_SOURCE            0\n",
      "RELATION           1978\n",
      "MOA               14638\n",
      "MOA_SOURCE        14638\n",
      "ACT_SOURCE_URL     6139\n",
      "MOA_SOURCE_URL    14649\n",
      "ACTION_TYPE       13391\n",
      "TDL                4722\n",
      "ORGANISM            139\n",
      "dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Nombre de files i columnes.\n",
    "print(\"Nombre de files i columnes.\")\n",
    "print(\"files:\", df.shape[0])\n",
    "print(\"columnes:\", df.shape[1])\n",
    "\n",
    "# Nom de les variables.\n",
    "print(\"\\n\\n\\nNom de les variables:\")\n",
    "print(df.columns)\n",
    "\n",
    "# Nombre de missing values (NA) a cada una de les columnes.\n",
    "print(\"\\n\\n\\nNumero de NA:\\n\", df.isna().sum())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**c) De la base de dades DrugCentral, només considerarem les proteïnes humanes i els fàrmacs que tinguin definit un valor d’activitat (columna = `ACT_VALUE`). Mostra el nombre de files i columnes un cop filtrat.** _Nota: la resta d'exercicis es faran a partir del resultat d'aquest filtre_ [0.5 punts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DRUG_NAME</th>\n",
       "      <th>STRUCT_ID</th>\n",
       "      <th>TARGET_NAME</th>\n",
       "      <th>TARGET_CLASS</th>\n",
       "      <th>ACCESSION</th>\n",
       "      <th>GENE</th>\n",
       "      <th>SWISSPROT</th>\n",
       "      <th>ACT_VALUE</th>\n",
       "      <th>ACT_UNIT</th>\n",
       "      <th>ACT_TYPE</th>\n",
       "      <th>ACT_COMMENT</th>\n",
       "      <th>ACT_SOURCE</th>\n",
       "      <th>RELATION</th>\n",
       "      <th>MOA</th>\n",
       "      <th>MOA_SOURCE</th>\n",
       "      <th>ACT_SOURCE_URL</th>\n",
       "      <th>MOA_SOURCE_URL</th>\n",
       "      <th>ACTION_TYPE</th>\n",
       "      <th>TDL</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Cytochrome P450 2D6</td>\n",
       "      <td>Enzyme</td>\n",
       "      <td>P10635</td>\n",
       "      <td>CYP2D6</td>\n",
       "      <td>CP2D6_HUMAN</td>\n",
       "      <td>6.706859</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...</td>\n",
       "      <td>DRUG MATRIX</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily H me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q12809</td>\n",
       "      <td>KCNH2</td>\n",
       "      <td>KCNH2_HUMAN</td>\n",
       "      <td>4.890000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>Inhibition of wild-type human ERG channel expr...</td>\n",
       "      <td>CHEMBL</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ebi.ac.uk/chembl/compound/inspect/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Potassium voltage-gated channel subfamily D me...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>Q9UK17</td>\n",
       "      <td>KCND3</td>\n",
       "      <td>KCND3_HUMAN</td>\n",
       "      <td>4.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>levobupivacaine</td>\n",
       "      <td>4</td>\n",
       "      <td>Sodium channel protein type 1 subunit alpha</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>P35498</td>\n",
       "      <td>SCN1A</td>\n",
       "      <td>SCN1A_HUMAN</td>\n",
       "      <td>5.790000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WOMBAT-PK</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(S)-nitrendipine</td>\n",
       "      <td>6</td>\n",
       "      <td>Intermediate conductance calcium-activated pot...</td>\n",
       "      <td>Ion channel</td>\n",
       "      <td>O15554</td>\n",
       "      <td>KCNN4</td>\n",
       "      <td>KCNN4_HUMAN</td>\n",
       "      <td>7.600000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IUPHAR</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BLOCKER</td>\n",
       "      <td>Tchem</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17385</th>\n",
       "      <td>tucatinib</td>\n",
       "      <td>5389</td>\n",
       "      <td>Receptor tyrosine-protein kinase erbB-4</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>Q15303</td>\n",
       "      <td>ERBB4</td>\n",
       "      <td>ERBB4_HUMAN</td>\n",
       "      <td>6.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32241871</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17386</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 1</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P11362</td>\n",
       "      <td>FGFR1</td>\n",
       "      <td>FGFR1_HUMAN</td>\n",
       "      <td>9.400000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17387</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 2</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P21802</td>\n",
       "      <td>FGFR2</td>\n",
       "      <td>FGFR2_HUMAN</td>\n",
       "      <td>9.300000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17388</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 3</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P22607</td>\n",
       "      <td>FGFR3</td>\n",
       "      <td>FGFR3_HUMAN</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>DRUG LABEL</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17389</th>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>5390</td>\n",
       "      <td>Fibroblast growth factor receptor 4</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>P22455</td>\n",
       "      <td>FGFR4</td>\n",
       "      <td>FGFR4_HUMAN</td>\n",
       "      <td>7.520000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IC50</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SCIENTIFIC LITERATURE</td>\n",
       "      <td>=</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>http://www.ncbi.nlm.nih.gov/pubmed/32315352</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INHIBITOR</td>\n",
       "      <td>Tclin</td>\n",
       "      <td>Homo sapiens</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11391 rows × 20 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              DRUG_NAME  STRUCT_ID  \\\n",
       "1       levobupivacaine          4   \n",
       "2       levobupivacaine          4   \n",
       "3       levobupivacaine          4   \n",
       "5       levobupivacaine          4   \n",
       "9      (S)-nitrendipine          6   \n",
       "...                 ...        ...   \n",
       "17385         tucatinib       5389   \n",
       "17386       pemigatinib       5390   \n",
       "17387       pemigatinib       5390   \n",
       "17388       pemigatinib       5390   \n",
       "17389       pemigatinib       5390   \n",
       "\n",
       "                                             TARGET_NAME TARGET_CLASS  \\\n",
       "1                                    Cytochrome P450 2D6       Enzyme   \n",
       "2      Potassium voltage-gated channel subfamily H me...  Ion channel   \n",
       "3      Potassium voltage-gated channel subfamily D me...  Ion channel   \n",
       "5            Sodium channel protein type 1 subunit alpha  Ion channel   \n",
       "9      Intermediate conductance calcium-activated pot...  Ion channel   \n",
       "...                                                  ...          ...   \n",
       "17385            Receptor tyrosine-protein kinase erbB-4       Kinase   \n",
       "17386                Fibroblast growth factor receptor 1       Kinase   \n",
       "17387                Fibroblast growth factor receptor 2       Kinase   \n",
       "17388                Fibroblast growth factor receptor 3       Kinase   \n",
       "17389                Fibroblast growth factor receptor 4       Kinase   \n",
       "\n",
       "      ACCESSION    GENE    SWISSPROT  ACT_VALUE  ACT_UNIT ACT_TYPE  \\\n",
       "1        P10635  CYP2D6  CP2D6_HUMAN   6.706859       NaN     IC50   \n",
       "2        Q12809   KCNH2  KCNH2_HUMAN   4.890000       NaN     IC50   \n",
       "3        Q9UK17   KCND3  KCND3_HUMAN   4.500000       NaN     IC50   \n",
       "5        P35498   SCN1A  SCN1A_HUMAN   5.790000       NaN     IC50   \n",
       "9        O15554   KCNN4  KCNN4_HUMAN   7.600000       NaN     IC50   \n",
       "...         ...     ...          ...        ...       ...      ...   \n",
       "17385    Q15303   ERBB4  ERBB4_HUMAN   6.500000       NaN     IC50   \n",
       "17386    P11362   FGFR1  FGFR1_HUMAN   9.400000       NaN     IC50   \n",
       "17387    P21802   FGFR2  FGFR2_HUMAN   9.300000       NaN     IC50   \n",
       "17388    P22607   FGFR3  FGFR3_HUMAN   9.000000       NaN     IC50   \n",
       "17389    P22455   FGFR4  FGFR4_HUMAN   7.520000       NaN     IC50   \n",
       "\n",
       "                                             ACT_COMMENT  \\\n",
       "1      DRUGMATRIX: CYP450, 2D6 enzyme inhibition (sub...   \n",
       "2      Inhibition of wild-type human ERG channel expr...   \n",
       "3                                                    NaN   \n",
       "5                                                    NaN   \n",
       "9                                                    NaN   \n",
       "...                                                  ...   \n",
       "17385                                                NaN   \n",
       "17386                                                NaN   \n",
       "17387                                                NaN   \n",
       "17388                                                NaN   \n",
       "17389                                                NaN   \n",
       "\n",
       "                  ACT_SOURCE RELATION  MOA  MOA_SOURCE  \\\n",
       "1                DRUG MATRIX        =  NaN         NaN   \n",
       "2                     CHEMBL        =  NaN         NaN   \n",
       "3                  WOMBAT-PK        =  NaN         NaN   \n",
       "5                  WOMBAT-PK        =  NaN         NaN   \n",
       "9                     IUPHAR        =  NaN         NaN   \n",
       "...                      ...      ...  ...         ...   \n",
       "17385  SCIENTIFIC LITERATURE        =  NaN         NaN   \n",
       "17386  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17387  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17388  SCIENTIFIC LITERATURE        =  1.0  DRUG LABEL   \n",
       "17389  SCIENTIFIC LITERATURE        =  NaN         NaN   \n",
       "\n",
       "                                          ACT_SOURCE_URL  \\\n",
       "1                                                    NaN   \n",
       "2      https://www.ebi.ac.uk/chembl/compound/inspect/...   \n",
       "3                                                    NaN   \n",
       "5                                                    NaN   \n",
       "9                                                    NaN   \n",
       "...                                                  ...   \n",
       "17385        http://www.ncbi.nlm.nih.gov/pubmed/32241871   \n",
       "17386        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17387        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17388        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "17389        http://www.ncbi.nlm.nih.gov/pubmed/32315352   \n",
       "\n",
       "                                          MOA_SOURCE_URL ACTION_TYPE    TDL  \\\n",
       "1                                                    NaN         NaN  Tclin   \n",
       "2                                                    NaN         NaN  Tclin   \n",
       "3                                                    NaN         NaN  Tclin   \n",
       "5                                                    NaN         NaN  Tclin   \n",
       "9                                                    NaN     BLOCKER  Tchem   \n",
       "...                                                  ...         ...    ...   \n",
       "17385                                                NaN   INHIBITOR  Tclin   \n",
       "17386  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17387  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17388  https://www.accessdata.fda.gov/drugsatfda_docs...   INHIBITOR  Tclin   \n",
       "17389                                                NaN   INHIBITOR  Tclin   \n",
       "\n",
       "           ORGANISM  \n",
       "1      Homo sapiens  \n",
       "2      Homo sapiens  \n",
       "3      Homo sapiens  \n",
       "5      Homo sapiens  \n",
       "9      Homo sapiens  \n",
       "...             ...  \n",
       "17385  Homo sapiens  \n",
       "17386  Homo sapiens  \n",
       "17387  Homo sapiens  \n",
       "17388  Homo sapiens  \n",
       "17389  Homo sapiens  \n",
       "\n",
       "[11391 rows x 20 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_filtered = df[(df['ORGANISM'] == 'Homo sapiens') & df['ACT_VALUE'].notnull()]\n",
    "df_filtered"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**d) Per quants fàrmacs (columna=`drugs`) hi ha dades? I per a quantes proteïnes (columna=`targets`)?** [0.5 punts] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nombre de fàrmacs amb dades: 1767\n",
      "Nombre de proteïnes amb dades: 1357\n"
     ]
    }
   ],
   "source": [
    "# Nombre de fàrmacs amb dades (columna=drugs)\n",
    "num_drugs = df_filtered['DRUG_NAME'].nunique()\n",
    "\n",
    "# Nombre de proteïnes amb dades (columna=targets)\n",
    "num_targets = df_filtered['TARGET_NAME'].nunique()\n",
    "\n",
    "print(f\"Nombre de fàrmacs amb dades: {num_drugs}\")\n",
    "print(f\"Nombre de proteïnes amb dades: {num_targets}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Exploració de la base de dades\n",
    "\n",
    "**a) Quin és el fàrmac amb més interaccions? Cerqueu per a què serveix aquest fàrmac** [0.5 punts] \n",
    "\n",
    "Considerem cada interacció quan es testeja un fàrmac amb una proteïna diferent. Com més alt és el valor d'afinitat (unitats en -log[M]), voldrà dir que la interacció és més forta i per tant, que el fàrmac té una forta atracció per la proteïna. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "El fàrmac amb més interaccions és: sunitinib\n",
      "Nombre total d'interaccions: 263\n",
      "\n",
      "Cerca de sunitinib:\n",
      "Sunitinib is a receptor tyrosine kinase inhibitor and chemotherapeutic agent used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).\n"
     ]
    }
   ],
   "source": [
    "# Agrupar per fàrmac i comptar el nombre d'interaccions per cada fàrmac\n",
    "interactions_count = df_filtered['DRUG_NAME'].value_counts()\n",
    "\n",
    "# Obtenir el fàrmac amb més interaccions\n",
    "most_interactions_drug = interactions_count.idxmax()\n",
    "num_interactions = interactions_count.max()\n",
    "\n",
    "print(f\"El fàrmac amb més interaccions és: {most_interactions_drug}\")\n",
    "print(f\"Nombre total d'interaccions: {num_interactions}\\n\")\n",
    "print(f\"Cerca de {most_interactions_drug}:\")\n",
    "# Els farmacs el buco a DrugBank\n",
    "print(\"Sunitinib is a receptor tyrosine kinase inhibitor and chemotherapeutic agent used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**b) I la proteïna amb més fàrmacs associats? Cerqueu què fa aquesta proteïna al nostre organisme.** [0.5 punts] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "La proteïna amb més fàrmacs associats és: 5-hydroxytryptamine receptor 2A\n",
      "Nombre total de fàrmacs associats: 169\n",
      "Cerca de 5-hydroxytryptamine receptor 2A:\n",
      "General Function: Acts as a receptor for serotonin, a neurotransmitter involved in neural activity, perception, cognition, and mood regulation.\n"
     ]
    }
   ],
   "source": [
    "# Agrupar per proteïna i comptar el nombre de fàrmacs associats a cada proteïna\n",
    "proteins_count = df_filtered['TARGET_NAME'].value_counts()\n",
    "\n",
    "# Obtenir la proteïna amb més fàrmacs associats\n",
    "most_associated_protein = proteins_count.idxmax()\n",
    "num_associated_drugs = proteins_count.max()\n",
    "\n",
    "print(f\"La proteïna amb més fàrmacs associats és: {most_associated_protein}\")\n",
    "print(f\"Nombre total de fàrmacs associats: {num_associated_drugs}\")\n",
    "print(f\"Cerca de {most_associated_protein}:\")\n",
    "# Les proteïnes les bsuco a uniprot\n",
    "print(\"General Function: Acts as a receptor for serotonin, a neurotransmitter involved in neural activity, perception, cognition, and mood regulation.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**c) Les interaccions es classifiquen segons si estan involucrades en el __mecanisme d’acció__ del fàrmac, és a dir, si aquesta interacció és la responsable del seu efecte terapèutic. A la columna `MOA` (Mechanism Of Action) s'indica amb un 1 si la interacció correspont a l'efecte terapèutic. Per tant, repetiu els dos apartats anteriors per a determinar quin fàrmac i proteïna tenen més interaccions si només tenim en compte les interaccions involucrades en el `MOA`.** [1 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "El fàrmac amb més interaccions en el MOA és: ethoxzolamide\n",
      "Nombre total d'interaccions en el MOA: 13\n",
      "Cerca de ethoxzolamide:\n",
      "For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy.\n",
      "\n",
      "La proteïna amb més fàrmacs associats en el MOA és: D(2) dopamine receptor\n",
      "Nombre total de fàrmacs associats en el MOA: 54\n",
      "Cerca de D(2) dopamine receptor:\n",
      "this protein exhibits a multifaceted role in regulating metabolic processes, responding to stress, and influencing cellular activities related to insulin sensitivity, obesity, mitochondrial function, and musculoskeletal health.\n"
     ]
    }
   ],
   "source": [
    "# Filtrar per interaccions involucrades en el MOA (MOA = 1)\n",
    "df_moa = df_filtered[df_filtered['MOA'] == 1]\n",
    "\n",
    "# Trobar el fàrmac amb més interaccions en el MOA\n",
    "most_interactions_drug_moa = df_moa['DRUG_NAME'].value_counts().idxmax()\n",
    "num_interactions_moa_drug = df_moa['DRUG_NAME'].value_counts().max()\n",
    "\n",
    "print(f\"El fàrmac amb més interaccions en el MOA és: {most_interactions_drug_moa}\")\n",
    "print(f\"Nombre total d'interaccions en el MOA: {num_interactions_moa_drug}\")\n",
    "print(f\"Cerca de {most_interactions_drug_moa}:\")\n",
    "print(\"For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy.\")\n",
    "\n",
    "# Trobar la proteïna amb més fàrmacs associats en el MOA\n",
    "most_associated_protein_moa = df_moa['TARGET_NAME'].value_counts().idxmax()\n",
    "num_associated_drugs_moa = df_moa['TARGET_NAME'].value_counts().max()\n",
    "\n",
    "print(f\"\\nLa proteïna amb més fàrmacs associats en el MOA és: {most_associated_protein_moa}\")\n",
    "print(f\"Nombre total de fàrmacs associats en el MOA: {num_associated_drugs_moa}\")\n",
    "print(f\"Cerca de {most_associated_protein_moa}:\")\n",
    "print(\"this protein exhibits a multifaceted role in regulating metabolic processes, responding to stress, and influencing cellular activities related to insulin sensitivity, obesity, mitochondrial function, and musculoskeletal health.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**d) Cada proteïna, segons la seva funció, està assignada a una classe (columna=`TARGET_CLASS`). Quantes classes hi ha i quines són? Quantes proteïnes té assignada cada classe (noms de les proteïnes sense repetir)?** [1 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hi ha 21 classes:\n",
      "Classe 0: Adhesion, Proteïnes assignades: 5\n",
      "Classe 1: Antibody, Proteïnes assignades: 1\n",
      "Classe 2: CD molecules, Proteïnes assignades: 1\n",
      "Classe 3: Cytokine, Proteïnes assignades: 14\n",
      "Classe 4: Cytosolic other, Proteïnes assignades: 19\n",
      "Classe 5: Enzyme, Proteïnes assignades: 377\n",
      "Classe 6: GPCR, Proteïnes assignades: 174\n",
      "Classe 7: Glycoprotein, Proteïnes assignades: 1\n",
      "Classe 8: Ion channel, Proteïnes assignades: 160\n",
      "Classe 9: Kinase, Proteïnes assignades: 405\n",
      "Classe 10: Membrane other, Proteïnes assignades: 1\n",
      "Classe 11: Membrane receptor, Proteïnes assignades: 20\n",
      "Classe 12: Nuclear hormone receptor, Proteïnes assignades: 28\n",
      "Classe 13: Nuclear other, Proteïnes assignades: 2\n",
      "Classe 14: Secreted, Proteïnes assignades: 12\n",
      "Classe 15: Structural, Proteïnes assignades: 6\n",
      "Classe 16: Surface antigen, Proteïnes assignades: 6\n",
      "Classe 17: Transcription factor, Proteïnes assignades: 6\n",
      "Classe 18: Transporter, Proteïnes assignades: 63\n",
      "Classe 19: Tumour-associated antigen, Proteïnes assignades: 3\n",
      "Classe 20: Unclassified, Proteïnes assignades: 53\n"
     ]
    }
   ],
   "source": [
    "# Comptar les proteïnes per classe\n",
    "proteins_per_class = df_filtered.groupby('TARGET_CLASS')['TARGET_NAME'].nunique()\n",
    "\n",
    "# Nombres de classes i noms de les proteïnes per classe\n",
    "num_classes = proteins_per_class.shape[0]\n",
    "class_names = proteins_per_class.index.tolist()\n",
    "proteins_count_per_class = proteins_per_class.tolist()\n",
    "\n",
    "# Mostrar els resultats\n",
    "print(f\"Hi ha {num_classes} classes:\")\n",
    "for i in range(num_classes):\n",
    "    print(f\"Classe {i}: {class_names[i]}, Proteïnes assignades: {proteins_count_per_class[i]}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**e) Feu un gràfic de barres (bar plot) on es mostri aquesta informació (x=`TARGET_CLASS`; y = nº de proteïnes corresponent a cada classe).** Recordeu que un gràfic s'ha de poder interpretar per si mateix, així que incloeu totes les etiquetes que considereu necessàries i formatejeu-lo al vostre gust.  [1 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "proteins_per_class\n",
    "proteins_per_class.plot(kind='bar', color='skyblue')\n",
    "\n",
    "# Afegir etiquetes i títol al gràfic\n",
    "plt.xlabel('Classe de Proteïnes')\n",
    "plt.ylabel('Nombre de Proteïnes')\n",
    "plt.title('Nombre de Proteïnes per Classe')\n",
    "\n",
    "# Mostrar el gràfic\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Manipulació de les dades\n",
    "\n",
    "**a) És conegut que els fàrmacs generalment interaccionen amb més d’una proteïna, una de les raons per la qual tots els fàrmacs poden tenir efectes secundaris. Amb quantes proteïnes de mitjana interaccionen els fàrmacs? És el mateix valor per a totes les classes de proteïna ?**  _Nota: Per obtenir el valor mitjà per una determinada classe considereu únicament les interaccions que involucren a aquella classe._ [1.5 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mitjana d'interaccions de fàrmacs amb proteïnes per a totes les classes: 6.45\n"
     ]
    }
   ],
   "source": [
    "# Calcular la mitjana del nombre de proteïnes amb les quals interaccionen els fàrmacs\n",
    "average_interactions_all_class = round(df_filtered.groupby('DRUG_NAME')['TARGET_NAME'].nunique().mean(), 2)\n",
    "print(f\"Mitjana d'interaccions de fàrmacs amb proteïnes per a totes les classes: {average_interactions_all_class}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Mitjana d'interaccions de fàrmacs amb proteïnes per a cada classe:\n",
      "TARGET_CLASS\n",
      "Adhesion                      1.000000\n",
      "Antibody                      1.000000\n",
      "CD molecules                  1.000000\n",
      "Cytokine                      1.260870\n",
      "Cytosolic other               1.210526\n",
      "Enzyme                        2.715019\n",
      "GPCR                          5.319790\n",
      "Glycoprotein                  1.000000\n",
      "Ion channel                   2.237598\n",
      "Kinase                       14.435233\n",
      "Membrane other                1.000000\n",
      "Membrane receptor             1.041667\n",
      "Nuclear hormone receptor      2.018293\n",
      "Nuclear other                 1.000000\n",
      "Secreted                      1.338983\n",
      "Structural                    1.250000\n",
      "Surface antigen               1.153846\n",
      "Transcription factor          1.181818\n",
      "Transporter                   2.112565\n",
      "Tumour-associated antigen     1.000000\n",
      "Unclassified                  1.237288\n",
      "Name: TARGET_NAME, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# Mitjana d'interaccions per a cada classe de proteïna\n",
    "proteins_per_class = df_filtered.groupby(['DRUG_NAME', 'TARGET_CLASS'])['TARGET_NAME'].nunique()\n",
    "average_interactions_per_class = proteins_per_class.groupby('TARGET_CLASS').mean()\n",
    "print(\"\\nMitjana d'interaccions de fàrmacs amb proteïnes per a cada classe:\")\n",
    "print(average_interactions_per_class)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**b) Quin és el perfil dels valors d’afinitat que hi ha en les interaccions (columna = `ACT_VALUE`)? Hi ha alguna diferència entre les interaccions involucrades en el mecanisme d’acció dels fàrmacs i la resta (output de la pregunta 2.C)? Il·lustreu-ho amb un gràfic, per exemple, un histograma on es mostri el perfil dels valors d'afinitat generals i els valors implicats en el MOA.** [1 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Filtrar les interaccions en general\n",
    "general_interactions = df_filtered['ACT_VALUE'].dropna()\n",
    "\n",
    "# Filtrar les interaccions involucrades en el MOA\n",
    "moa_interactions = df_filtered[df_filtered['MOA'] == 1]['ACT_VALUE'].dropna()\n",
    "\n",
    "# Crear l'histograma\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.hist(general_interactions, bins=50, alpha=0.7, label='Interaccions Generals', color='pink')#skyblue\n",
    "plt.hist(moa_interactions, bins=50, alpha=0.7, label='Interaccions en el MOA', color='red')#orange\n",
    "\n",
    "# Afegir etiquetes i títol al gràfic\n",
    "plt.xlabel('Valor d\\'Afinitat')\n",
    "plt.ylabel('Nombre d\\'Interaccions')\n",
    "plt.title('Perfil dels Valors d\\'Afinitat per Interaccions Generals i en el MOA')\n",
    "\n",
    "# Afegir llegenda\n",
    "plt.legend()\n",
    "\n",
    "# Mostrar el gràfic\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 4. Anàlisi d'una proteïna\n",
    "\n",
    "S’ha observat que els fàrmacs que actuen sobre una proteïna anomenada hERG (gen KCNH2) poden produir efectes adversos seriosos. Aquesta proteïna és un canal de ions de potassi i alterar la seva funció pot produir el que es coneix com _torsade des pointes_, una alteració de l’electrocardiograma que pot degenerar en fibril·lació ventricular i mort sobtada.\n",
    "\n",
    "**a) Quants fàrmacs hi ha amb activitat per aquesta proteïna? (columna = `GENE`)** [0.5 punts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hi ha 152 fàrmacs amb activitat per a la proteïna hERG.\n"
     ]
    }
   ],
   "source": [
    "# Filtrar les files on la columna 'GENE' és igual a 'KCNH2' (proteïna hERG)\n",
    "herg_drugs = df_filtered[df_filtered['GENE'] == 'KCNH2']\n",
    "\n",
    "# Obtenir el nombre de fàrmacs amb activitat per a la proteïna hERG\n",
    "num_herg_drugs = herg_drugs['DRUG_NAME'].nunique()\n",
    "\n",
    "print(f\"Hi ha {num_herg_drugs} fàrmacs amb activitat per a la proteïna hERG.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**b) Com a regla general sabem que una activitat pot començar a ser rellevant si és superior a 5 (equivalent a 10 μM) (Recordem que com més alt és el logaritme del valor d'activitat, més forta és la interacció). Genereu un fitxer amb les interaccions sospitoses (activitat >=5) de produir _torsade des pointes_ ordenat per la seva afinitat pel canal hERG de més gran a més petit.** [1 punt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Filtrar les interaccions amb activitat >= 5 per al canal hERG\n",
    "suspicious_interactions = df_filtered[(df_filtered['GENE'] == 'KCNH2') & (df_filtered['ACT_VALUE'] >= 5)]\n",
    "\n",
    "# Ordenar les interaccions per afinitat de més gran a més petit\n",
    "sorted_interactions = suspicious_interactions.sort_values(by='ACT_VALUE', ascending=False)\n",
    "\n",
    "# Guardar el DataFrame amb les interaccions sospitoses en un fitxer CSV\n",
    "sorted_interactions.to_csv('interaccions_sospitoses_hERG.csv', index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**c) Comproveu si és veritat per als tres primers fàrmacs obtinguts cercant bibliografia.** [0.5 punts]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "1. Astemizole (ACT_VALUE=9.04)\n",
    "    Astemizole is a long-acting, non-sedating second generation antihistamine used in the treatment of allergy symptoms. It was withdrawn from market by the manufacturer in 1999 due to the potential to cause arrhythmias at high doses, especially when when taken with CYP inhibitors or grapefruit juice.\n",
    "    Summary: It is a second generation antihistamine used to treat allergy symptoms.\n",
    "   Resposta: Aquest estudi específic confirma que astemizol, un fàrmac que actua sobre la proteïna hERG, pot estar associat amb arrítmies ventriculars serioses com torsades de pointes.\n",
    "   https://pubmed.ncbi.nlm.nih.gov/9583453/\n",
    "   \n",
    "2. Sertindole (ACT_VALUE=8.57)\n",
    "   Sertindole, a neuroleptic, is one of the newer antipsychotic medications available. Serdolect is developed by the Danish pharmaceutical company H. Lundbeck. It is a phenylindole derivative used in the treatment of schizophrenia. It was first marketed in 1996 in several European countries before being withdrawn two years later because of numerous cardiac adverse effects. It has once again been approved and should soon be available on the French and Australian market.\n",
    "    Summary: It is an atypical antipsychotic indicated in the treatment of schizophrenia.\n",
    "    Resposta: Aquest es l'article que explica que pot haver efectes adversos serios: https://pubmed.ncbi.nlm.nih.gov/11691681/ . Els fàrmacs antipsicòtics poden estar associats amb l'allargament del QTc interval, torsades de pointes i mort sobtada.\n",
    "   \n",
    "3. Benperidol (ACT_VALUE=8.47)\n",
    "   Benperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.\n",
    "   Resposta: És veritat que el Benperidol pot causar efectes adversos seriosos.  Aquest article https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221427/ sosté que molts fàrmacs psicotròpics poden produir efectes adversos seriosos, específicament allargament del QTc i el risc associat de torsades de pointes (TdP), que és una taquiarritmia ventricular greu. Algunes de les substàncies esmentades en l'article, com thioridazine i ziprasidone, es destaquen com a fàrmacs amb un alt risc d'induir aquests efectes adversos.\n",
    "\n",
    "Pd: Tot el que he buscat per aquest exercisi ho he tret de Pubmed i DrugBank\n",
    "\n",
    "\n",
    "Pd2: Bibliografia de l'activitat:\n",
    "        - DrugBank\n",
    "        - Uniprot\n",
    "        - PubMed"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "maria",
   "language": "python",
   "name": "maria"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
